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Axon regeneration failure accounts for permanent
functional deficits following CNS injury in adult
mammals. However, the underlying mechanisms
remain elusive. In analyzing axon regeneration in
different mutant mouse lines, we discovered that
deletion of suppressor of cytokine signaling 3
(SOCS3) in adult retinal ganglion cells (RGCs)
promotes robust regeneration of injured optic nerve
axons. This regeneration-promoting effect is effi-
ciently blocked in SOCS3-gp130 double-knockout
mice, suggesting that SOCS3 deletion promotes
axon regeneration via a gp130-dependent pathway.
Consistently, a transient upregulation of ciliary neuro-
trophic factor (CNTF) was observed within the retina
following optic nerve injury. Intravitreal application
of CNTF further enhances axon regeneration from
SOCS3-deleted RGCs. Together, our results suggest
that compromised responsiveness to injury-induced
growth factors in mature neurons contributes signifi-
cantly to regeneration failure. Thus, developing strat-
egies to modulate negative signaling regulators may
be an efficient strategy of promoting axon regenera-
tion after CNS injury.
INTRODUCTION
A salient feature of axon regeneration in mammals is the drastic
difference between the peripheral nervous system (PNS) versus
the central nervous system (CNS). In contrast to robust axon
regeneration in the PNS neurons, regenerative growth in the
adult CNS is minimal. Previous studies have been aimed at
characterizing environmental inhibitory molecules in the adult
CNS (reviewed by Harel and Strittmatter, 2006; Schwab and
Bartholdi, 1996; Yiu and He, 2006). While several myelin-associ-
ated molecules and chondroitin sulfate proteoglycans (CSPGs)
in the glial scar have been implicated as inhibitors of axon regen-
eration (Filbin, 2006; Fitch and Silver, 2008), blockade of these
inhibitory signals results in limited axon regeneration (Case and
Tessier-Lavigne, 2005).An alternate explanation is that the adult PNS and CNS neurons
differ in intrinsic growth ability (Goldberg and Barres, 2000; Zhou
and Snider, 2006). Current hypotheses suggest that adult CNS
neurons lose axonal growth ability. Several potential players
have been implicated, such as development-dependent decline
of neuronal cAMP levels (Cai et al., 2001) or Bcl-2 (Cho et al.,
2005). Goldberg et al. (2002) found a dramatic decrease in axonal
growth rates of dissociated RGCs at the neonatal stage and sug-
gested that this may be triggered by signals from amacrine cells.
However, the molecular nature of such signals still remains
unclear. Furthermore, other mechanisms might be involved in
the transition from the rapid growth mode of immature neurons
to the poor growth mode of mature CNS neurons.
In an effort to identify molecular pathways that limit the
intrinsic regenerative capacity of adult RGCs, we discovered
that deletion of phosphatase and tensin homolog (PTEN) or
tuberous sclerosis protein 1 (TSC1), two negative regulators of
the mammalian target of rapamycin (mTOR) pathway, in adult
RGCs promotes robust axon regeneration following optic nerve
injury (Park et al., 2008). We also found that axotomy triggers
a dramatic downregulation of mTOR activity in adult RGCs.
Given the well-established role of mTOR in regulating cap-
dependent protein translation (Ma and Blenis, 2009), our results
indicate that the diminished ability to synthesize new proteins
contributes significantly to the failure of axon regeneration in
adult RGCs. However, despite increased mTOR activity, PTEN
or TSC1-deleted RGCs initiate axon regrowth only after axonal
injury, suggesting that injury-induced signals may be required
to activate the axonal regeneration program.
What injury-triggered signals can promote axon regeneration?
Studies in the PNS implicate several mechanisms, including
injury-induced cytokines and growth factors (Zigmond et al.,
1996), local protein synthesis, and increased axonal transport
of signaling components (Hanz et al., 2003). For example, sciatic
nerve lesion promotes expression of interleukin 6 (IL6) in axo-
tomized sensory neurons and/or Schwann cells in the lesion
sites, subsequently activating the JAK/STAT pathway in injured
sensory neurons (Cafferty et al., 2001; Cao et al., 2006). Activa-
tion of this pathway correlates with enhanced axonal regenera-
tive responses in DRG neurons (Miao et al., 2006). While IL6
can increase axonal growth in vitro and in vivo (Cafferty et al.,
2001; Cao et al., 2006), IL6 knockout mice show normal axon
regeneration (Cao et al., 2006). Thus, how this and other relatedNeuron 64, 617–623, December 10, 2009 ª2009 Elsevier Inc. 617
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remains unclear. A further question is whether these injury
signals exist in the CNS. In this study, we present genetic results
demonstrating a role of the gp130-dependent pathway in
promoting axon regeneration in adult RGCs.
RESULTS
SOCS3 Deletion Promotes Optic Nerve Regeneration
in Adult Mice
To identify molecular pathways critical to axon regeneration, we
applied optic nerve crush injury to assess axon regeneration in
conditional floxed mice (Park et al., 2008). Intravitreal application
of recombinant adeno-associated viruses expressing Cre (AAV-
Cre) results in Cre-dependent reporter expression in more than
90% of RGCs and thus was used to delete floxed genes in
mature RGCs in vivo. Regeneration of injured optic nerve axons
was traced by injecting cholera toxin beta subunit (CTB), an
anterograde tracer, into the vitreous of the retina. Neuronal
survival was assessed by immunostaining the whole-mount
sections with an anti-b-III tubulin antibody.
We observed significant axon regeneration in SOCS3
conditional knockout mice. In AAV-GFP (control) treated
SOCS3f/f mice (Mori et al., 2004), a few axonal sprouts could
be found close to the crush site, but none extended distally
beyond 500 mm (Figures 1A and 1F). However, AAV-Cre treated
SOCS3f/f mice exhibited significant enhancement in the number
of regenerating axons beyond the crush site (Figures 1B and 1F).
Cell viability analysis revealed significant increase of neuronal
survival following optic nerve crush in SOCS3-deleted mice
(Figures 1G and 1H). A similar regeneration phenotype was
seen in the SOCS3f/f mice crossed with a Thy1-Cre line, where
Cre expression starts from embryonic stages (Dewachter et al.,
2002) (data not shown). Taken together, our results suggest
that SOCS3 deletion in RGCs promotes both neuronal survival
and axon regeneration following optic crush injury.
To examine the temporal effects of SOCS3 deletion, we
assessed axon regeneration in SOCS3 conditional knockout
mice at different postinjury time points. At 1 day postcrush
(1 dpc), CTB-labeled axons stopped at the crush site, with no
labeled fibers found distal to the lesion site (Figure 1C). At
3 dpc, a few short sprouts could be seen close to the lesion site
(Figure 1D). However, at 7 dpc, more regenerating axons were
observed beyond the crush site (Figure 1E). The AAV-GFP-
injected control animals showed no axons beyond the lesion
site at any time point (data not shown). This differs from the obser-
vation of numerous axonal sprouts seen at 3 dpc in PTEN-deleted
mice (Park et al., 2008), suggesting that the majority of axon
regeneration in SOCS3-deleted RGCs starts between 3 and 7
days postinjury. Glial scar responses were similar in both control
and SOCS3-deleted mice (Figure S1), suggesting that SOCS3
deletion in RGCs did not affect glial responses in the lesion site.
Alteration of mTOR Activity in SOCS3-Deleted RGCs
after Injury
Our previous studies suggested that mTOR activity is an impor-
tant indicator of axon regenerative ability in RGCs (Park et al.,
2008). We therefore assessed the regulation of mTOR activity618 Neuron 64, 617–623, December 10, 2009 ª2009 Elsevier Inc.in SOCS3-deleted RGCs following optic nerve injury by immuno-
histochemical staining of anti-phospho-S6 (p-S6) antibody,
a marker of the mTOR activity (Park et al., 2008). In uninjured
SOCS3f/f mice injected with either AAV-GFP (Figures 2A and
2C) or AAV-Cre (Figures 2B and 2C), similar percentages
(8%–10%) of RGCs showed detectable p-S6 signals, implying
that SOCS3 deletion does not affect the basal levels of mTOR
activity of RGCs. As previously reported (Park et al., 2008),
p-S6 levels are significantly reduced following optic nerve crush
injury. In SOCS3f/f mice, p-S6 signal is reduced at 1 dpc in both
Figure 1. SOCS3 Deletion Promotes RGC Axon Regeneration
(A–E) Confocal images of optic nerves showing CTB-labeled axons around the
lesion sites at 14 days (A and B), 1 day (C), 3 days (D), and 7 days (E) postcrush
injury (dpc) from SOCS3f/f mice injected with AAV-GFP (A) or AAV-Cre (B–E). *,
crush site. Scale bar, 100 mm. (F) Quantification of regenerating axons at
different distances distal to the lesion sites at 14 days after crush injury. At least
five different sections (every fourth section) from each animal were quantified.
At 14 dpc, there were significant differences between control and SOCS3-
deleted mice groups (ANOVA with Bonferroni’s post-test, p < 0.05 for each
distance, eight animals in each group). (G) Fluorescent photomicrographs of
retinal whole mounts showing surviving TUJ1+ RGCs at 14 days after injury.
Scale bar, 50 mm. (H) Quantification of RGC survival at 14 dpc, expressed as
a percentage of the total number of TUJ1+ RGCs in the contralateral (intact)
retina (n = 8 for each group). For each retina, 15–20 fields were chosen from
different parts of the retina. The total viable RGC number was obtained by
multiplying the average number per field of TUJ1+ cells in the ganglion cell
layer by the retinal area. *p < 0.01, Dunnett’s test.
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SOCS3 deletion does not alter axotomy-triggered mTOR down-
regulation in the early postinjury stage.
Significant differences in these groups appear at later time
points. In the control group (SOCS3f/f with AAV-GFP), the
percentages of p-S6-positive RGCs continue to decrease at
7 dpc (Figures 2A and 2C). However, SOCS3-deleted mice
(SOCS3f/f with AAV-Cre) showed a significant recovery in the
percentage of p-S6-positive RGCs starting at 3 dpc (Figures
2B and 2C). By 7 dpc, coinciding with the appearance of larger
numbers of regenerating axons (Figures 1E and 1G), these
SOCS3-deleted mice had percentages (8%) of p-S6-positive
RGCs approaching levels observed before injury (Figures 2B
and 2C). Thus, despite an initial injury-induced mTOR downregu-
lation, SOCS3-deleted RGCs recover mTOR activity at late time
points. Since SOCS3 is a negative regulator of signaling path-
ways in response to cytokines and perhaps other growth factors
Figure 2. Phospho-S6 Levels in RGCs of SOCS3f/f
Mice with AAV-GFP or AAV-Cre after Optic Nerve
Injury
(A and B) Immunofluorescence analysis with anti-p-S6 or TUJ-
1 antibodies of the retinal sections from SOCS3f/f mice in-
jected with AAV-GFP (A) or AAV-Cre (B) at different time points
postcrush. Scale bar, 50 mm. (C) Quantification of p-S6+
RGCs. Data are presented as mean percentages of p-
S6+and TUJ1+ cells among total TUJ1+ cells in the ganglion
cell layer of each retina. Cell counts were performed on at least
four nonconsecutive sections for each animal, from four or five
mice per group. *p < 0.01 by Dunnett’s test.
(Croker et al., 2008), SOCS3 deletion may allow
RGCs to respond to injury-triggered factors, result-
ing in restoration of mTOR activity.
gp130 Deletion Abolishes Axon
Regeneration-Promoting Effect
of SOCS3 Knockout
SOCS3 was initially identified as a negative regu-
lator of the JAK/STAT signaling pathway triggered
by gp130 ligands such as interleukin-6, CNTF,
and cardiotrophin-1 (Croker et al., 2008; Pennica
et al., 1996). Most adult RGCs express both
SOCS3 and gp130 (Figure S2). We attempted to
examine the activation of gp130-dependent path-
ways by immunohistochemical methods but failed
to detect tyrosine phosphorylated STAT3 with
available antibodies. This might be due to low
abundance of tyrosine phosphorylated STAT3
protein within adult RGCs, as the same antibodies
could detect specific signals in axotomized DRG
neurons (data not shown).
To directly test the contribution of gp130-depen-
dent pathways to the effects of SOCS3 deletion on
axon regeneration, we crossed gp130f/f mice (Betz
et al., 1998) and SOCS3f/f mice to generate mutants
carrying two floxed genes. The double mutants
received intravitreal viral injection to induce the dele-
tion of both genes in RGCs. As expected,SOCS3deletion resulted
in increased neuronal survival and axon regeneration (Figures 3A,
3D, 3E, and 3H). However, gp130 knockout did not alter the
survival of injured RGCs or regeneration of injured optic nerve
axons (Figures 3B, 3D, 3F, and 3H). Interestingly, double knockout
ofSOCS3 andgp130 revealed a significant loss of the axon regen-
eration observed in SOCS3-deleted mice (Figures 3C and 3D),
suggesting that axon regeneration induced by SOCS3 deletion is
largely dependent upon gp130-mediated signaling.
Surprisingly, neuronal survival in the double mutants is higher
than controls (SOCS3f/f mice with AAV-GFP) or gp130f/f with
AAV-Cre (Figures 3G and 3H), suggesting a contribution of
gp130-independent pathways to the effects of SOCS3 deletion
on neuronal survival. Thus, our results indicate that while gp130-
dependent pathways are required for axonal regeneration, both
gp130-dependent and gp130-independent pathways might be
involved in neuronal survival effects of SOCS3 deletion.Neuron 64, 617–623, December 10, 2009 ª2009 Elsevier Inc. 619
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Nerve Injury
We next investigated the possible identity of gp130-dependent
ligands that could be responsible for promoting axon regenera-
tion following injury in SOCS3-deleted RGCs. These ligands
could be derived from either glial cells in the lesion site and/or
Figure 3. gp130 Codeletion Abolishes Axon Regeneration Effects of
SOCS3 Knockout
(A–C) Confocal images of optic nerves showing CTB-labeled axons around the
lesion sites at 14 days postcrush injury (dpc) from SOCS3f/f mice (A), gp130f/f
mice (B), or SOCS3f/f and gp130f/f mice (C) injected with AAV-Cre. *, crush site.
Scale bar, 100 mm. (D) Quantification of regenerating axons at different
distances distal to the lesion sites at 14 days after crush injury. At least five
different sections (every fourth section) from each animal were quantified.
There were significant differences between the SOCS3f/f group and the other
two groups (ANOVA with Bonferroni’s post-test p < 0.05 for each distance,
eight animals used in each groups). (E–G) Fluorescent photomicrographs of
retinal whole mounts showing surviving TUJ1+ RGCs at 14 days after injury
in AAV-Cre-injected SOCS3f/f (E), gp130f/f (F), or SOCS3f/f and gp130f/f (G)
mice. Scale bar, 50 mm. (H) Quantification of RGC survival at 14 dpc expressed
as a percentage of the total number of TUJ1+ RGCs in the contralateral (intact)
retina (n = 8 for each group). For each retina, 15–20 fields were chosen
from different parts of the retina. The total viable RGC number was obtained
by multiplying the average number per field of TUJ1+ cells in the ganglion
cell layer by the retinal area. There is a significant difference between the
SOCS3f/f group and gp130f/f group, but not between SOCS3f/f group and
SOCS3f/f/gp130f/f group (p < 0.05, ANOVA with post-hoc Tukey’s test).620 Neuron 64, 617–623, December 10, 2009 ª2009 Elsevier Inc.cells within the retina. To assess these possibilities, we used
an explant culture. AAV-Cre or AAV-GFP was injected to the
vitreous body of SOCS3f/f mice at the age of 4 weeks, and the
retina was dissected 14 days postinjection. In the explants
from the SOCS3f/f mice with AAV-GFP, only a few short sprouts
grew out (Figures S3A and S3C). However, in the explants
derived from SOCS3f/f mice with AAV-Cre, a dramatic increase
in the number of neurites extending from the explants was
observed (Figures S2B and S2C). These SOCS3-deleted retinal
explants show a dramatic increase in the number of neurites in
the absence of the injured optic nerve tissues, supporting the
possibility that retina-derived ligands act on the gp130 and its
coreceptors on RGCs.
Previous studies suggest a possible upregulation of CNTF
following injury (Mu¨ller et al., 2007; Park et al., 2009). We there-
fore examined by in situ hybridization the levels of CNTF, IL-6,
and cardiotrophin-1 following optic nerve injury. We observed
a modest but consistent increase of CNTF mRNA in the ganglion
cell layer of the mice at 6 hr after optic nerve injury (Figure S4B),
while the expression levels of IL6 and CT-1 are not altered
(Figures S4E and S4F and data not shown). However, we cannot
distinguish the identity of the retinal cell types expressing CNTF.
The upregulation of CNTF expression appears to be transient in
nature, since it returns to control levels after 24 hr postinjury
(Figure S4D). In line with this, a mild increase of SOCS3 mRNA
signal was also transiently increased (data not shown). These
results suggest that injury-induced upregulation of CNTF and
perhaps other gp130-dependent cytokines may account for
the effects of SOCS3 deletion on axon regeneration.
CNTF Enhances the Axon Regeneration-Promoting
Effect of SOCS3 Knockout
Our results suggest that SOCS3 deletion allows mature RGCs to
gain responsiveness to injury-induced cytokines. If this is the
case, exogenously provided CNTF should further enhance
axon regeneration from SOCS3-deleted RGCs. To test this, we
intravitreously injected 1 ml CNTF immediately before injury
and 3 days after injury. PBS-injected control animals (SOCS3f/f
with AAV-GFP) showed no sign of axon regeneration (Figures
4A, 4E, and 4F), while CNTF showed modest axon regeneration
in these control mice (Figures 4B, 4E, and 4F), consistent with
previous reports (Mu¨ller et al., 2009; Leaver et al., 2006).
SOCS3 knockout mice, treated with PBS, showed a similar
regeneration effect to that observed in noninjected animals
(Figures 4C, 4E, and 4F). In contrast, CNTF injection resulted
in a dramatic increase of axon regeneration in SOCS3-deleted
mice (Figures 4D, 4E, and 4F). The numbers and lengths of
regenerating axons are comparable to that seen after PTEN
deletion (Park et al., 2008). Thus, exogenous CNTF further
enhances axon regeneration from SOCS3-deleted RGCs
following optic nerve injury.
DISCUSSION
In this study, we show that SOCS3 deletion in RGCs promotes
dramatic axon regeneration following optic nerve injury in
a gp130-dependent manner. Importantly, exogenously delivered
CNTF could further enhance the extent of axon regeneration in
Neuron
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induced growth-promoting factors may be an important limiting
factor for successful axon regeneration in mature CNS neurons.
These findings also provide a plausible explanation for previous
observations that exogenously delivered cytokines have limited
effects on promoting survival and regeneration following optic
nerve injury (Cui et al., 1999; Watanabe et al., 2003) or spinal
cord injury (Lacroix et al., 2002).
In the adult CNS, the receptors and signaling molecules that
mediate the activity of CNTF and other cytokines are highly
expressed in glial cells (Scho¨bitz et al., 1992). Upon injury, upre-
gulated cytokines act as proinflammatory agents as a part of
a defense mechanism, but excessive or prolonged activation
could be detrimental to the CNS. SOCS3 family members, which
are rapidly upregulated by cytokines (Croker et al., 2008), are
crucial in executing tight control of the strength and duration of
these cytokine-triggered signaling pathways. Thus, it is possible
that limited regenerative responses of RGCs to injury-induced
CNTF could be, at least partially, attributed to this characteristic
tight regulatory mechanism of the JAK/STAT pathway.
Figure 4. Enhancement of Axon Regeneration in SOCS3-Deleted
Mice by CNTF
(A–D) Confocal images of optic nerves showing CTB-labeled axons around the
lesion sites at 14 days postcrush injury (dpc) from SOCS3f/f mice with AAV-
GFP (A and B) or AAV-Cre (C and D) and subsequent injection of PBS
(A and C) or CNTF (B and D). *, crush site. Scale bar, 100 mm. (E and F) Quan-
tification of regenerating axons at different distances (250–1000 mm in E and
1500–2500 mm in F) distal to the lesion sites at 14 days after crush injury. At
least five different sections (every fourth section) from each animal were quan-
tified. There were significant differences between the SOCS3f/f with CNTF
group and the other three groups (ANOVA with Bonferroni’s post-test, p <
0.05 for each distance, three animals in each group).Previous studies in culture showed that a specific JAK2 inhib-
itor does not affect the axonal growth of embryonic DRG neurons
but could efficiently block axonal elongation of adult sensory
neurons after a conditioning lesion (Liu and Snider, 2001; Neu-
mann and Woolf, 1999). Similarly, motoneuron-specific deletion
of STAT3 has no significant effect on the survival of embryonic
motoneurons, but results in increased death of motoneurons
after facial nerve injury (Schweizer et al., 2002). Together with
our findings, these studies suggest that gp130-dependent
signaling may be critical for injury-induced responses such as
neuronal survival and axon regeneration. In this regard, lens
injury has been shown to promote axon regeneration after optic
nerve injury (Fischer et al., 2000; Leon et al., 2000) and a combi-
natorial treatment of lens injury and cAMP agonists results in
robust axon regeneration (Mu¨ller et al., 2007). However, the
contribution of JAK/STAT pathway to these effects remains to
be determined (Cui et al., 2008).
How are cytokine-triggered pathways involved in controlling
neuronal survival and axon regeneration? In SOCS3-deleted
RGCs, mTOR is initially downregulated but recovers at later post-
injury points, in contrast to the rapid and persistent suppression
in injured RGCs in the control mice (Park et al., 2008). These
mTOR alterations correlate with the extent and time course of
axon regeneration observed in both PTEN and SOCS3-deleted
RGCs. These results support a model in which mTOR determines
the competence of regeneration in RGCs, while SOCS3-regu-
lated pathways act as an injury-induced signal that turns on the
regenerative program in injured RGCs. The dynamics of mTOR
activity implies that augmented and prolonged signaling events
as a result of SOCS3 deletion could allow injured neurons to
restore mTOR activity and regain axonal growth ability. Previous
studies suggest the involvement of several signaling pathways,
such as PI3K/akt, MAPK/ ERK, or JAK/STAT, in CNTF-triggered
effects on neuronal survival after injury (Park et al., 2004).
Thus, cytokine-triggered pathways may directly initiate an axon
regrowth program via these signaling pathways. On the other
hand, gp130-dependent signaling is required for axotomy-trig-
gered expression of neuropeptides such as pituitary adenylate
cyclase activating polypeptide (Habecker et al., 2009). Because
these neuropeptides have been shown to promote axon growth,
they might indirectly contribute to the survival and regeneration
effects observed in SOCS3-deleted mice.
Interestingly, while gp130 deletion abolishes the axon regen-
eration-promoting effect of SOCS3 knockout, a partial neuronal
survival effect is preserved in SOCS3 and gp130 double
mutants. In this regard, it has been previously shown that in
cultured nonneuronal cells, tyrosine phosphorylation of SOCS3
could be induced by gp130-independent growth factors such
as interleukin-2 and erythropoietin. In addition, tyrosine-phos-
phorylated SOCS3 not only inhibits STAT activation but also
binds to p120 RasGAP and activates Ras (Cacalano et al.,
2001). Given the established role of Ras in neuronal survival
(Reichardt, 2006), it will be interesting to determine whether
this or other mechanisms mediate the gp130-independent
survival effect of SOCS3 deletion.
Together with our previous finding of robust axon regeneration
in RGCs with deletion of PTEN or TSC1 (Park et al., 2008), our
current results reveal a critical limiting mechanism of CNSNeuron 64, 617–623, December 10, 2009 ª2009 Elsevier Inc. 621
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growth-promoting factors. Thus, targeting negative regulators
of signaling pathways of cytokine and growth factors to enhance
neuronal responses to growth-promoting factors may represent
a potential therapeutic strategy for promoting axon regeneration
following CNS injury in the adult. Future studies will be geared
toward determining whether these regenerating axons are able
to reconnect with their targets and assessing whether other
types of CNS neurons are sensitive to the manipulations of
gp130-dependent or -independent signaling pathways.
EXPERIMENTAL PROCEDURES
Mice, Intravitreal Injection, and Optic Nerve Injury
All experimental procedures were performed in compliance with animal proto-
cols approved by the IACUC at Children’s Hospital, Boston. C57BL6/J mice
or various floxed mice (aged p21) including SOCS3f/f and/ or gp130f/f were
injected intravitreally with 1 ml volume of AAV-GFP or AAV-Cre (titers at
0.5–1.0 3 1012) or CNTF (Peprotech, 1 mg/ml). Mice were anesthetized with
ketamine and xylazine. For each intravitreal injection, the micropipette was
inserted in peripheral retina, just behind the ora serrata, and was angled
to avoid damage to the lens. Two weeks after injection, the left ON was
exposed intraorbitally and crushed with jeweler’s forceps (Dumont #5; Roboz)
for 5 s1 mm behind the optic disc. To preserve the retinal blood supply, care
was taken not to damage the underlying ophthalmic artery. Mice received
a subcutaneous injection of buprenorphine as postoperative analgesic. Eye
ointment containing atropine sulfate was applied preoperatively to protect
the cornea during surgery. Complete optic nerve transection was verified by
demonstrating that both retrograde and anterograde tracers fail to reach the
retina or the superior colliculus, respectively, after lesion (Park et al., 2008).
Preparation of AAVs was described in Park et al. (2008).
RGC Axon Anterograde Labeling
For anterograde labeling of RGC axons, l ml of cholera toxin b subunit (CTB)
(2 mg/ml, Invitrogen) was injected into the vitreous with a Hamilton syringe.
Animals were given a lethal overdose of anesthesia and perfused with 4%
PFA. For the animals with an optic nerve injury, eyes with the nerve segment
still attached were dissected out and postfixed in the same fixative overnight
at 4C. Tissues were cryoprotected through increasing concentrations of
optimal cutting temperature compound (Tissue Tek). Eyes were snap-frozen
in dry ice and serial cross-sections (16 mm) were cut and stored at –20C. Optic
nerves were cut longitudinally (8 mm).
Regenerating RGC axons in injured optic nerves distal to the crush site were
quantified as described previously (Leon et al., 2000; Park et al., 2008). The
number of CTB-labeled axons was estimated by counting the number of
CTB-labeled fibers extending different distances from the end of the crush
site in five sections (every fourth section) per animal. The cross-sectional width
of the nerve was measured at the point at which the counts were taken and
was used to calculate the number of axons per millimeter of nerve width.
The number of axons per millimeter was averaged over all sections. Sad, the
total number of axons extending distance d in a nerve having a radius of r,
was estimated by summing over all sections having a thickness t (8 mm):
Sad = pr2 3 [average axons/mm]/t.
Retina Explant Culture
Four-week-old SOCS3f/f mice were intravitreally injected with AAV-Cre as the
treated group, or AAV-GFP as the control group (n = 4 each group). Retinas
were isolated after 14 days. Retinas were then cut into eight pieces radially
and cultured in laminin-poly-D-lysine-coated dishes. Culture medium was
Neurobasal-A with 5% B27 supplement (GIBCO), penicillin/streptomycin
(GIBCO), and glutamine (GIBCO). Explants were maintained for 4 days and
then fixed with 4% PFA. Outgrowing neurites were then stained with anti-
TUJ1 antibody. For each animal, fluorescent images of three or four pieces
of the explants were taken (1003, Nikon). With Metamorph software (Molec-
ular Devices), the edge of the explant was outlined and areas at 0–40 mm,622 Neuron 64, 617–623, December 10, 2009 ª2009 Elsevier Inc.40–80 mm, and 80–120 mm distal to the edge were defined all the way around
the explant. The numbers of neurites were counted in the three zones and
averaged over the three to four explants for each animal. The differences
between the two groups were analyzed using t test.
Details for the immunohistochemistry and in situ hybridization experiments
are provided in the Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and four
figures and can be found with this article online at http://www.cell.com/
neuron/supplemental/S0896-6273(09)00937-4.
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